- Home
- APPS vs ZVRA Comparison
APPS vs ZVRA Comparison
Compare APPS & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APPS | ZVRA |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 503.5M | 499.4M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | APPS | ZVRA |
|---|---|---|
| Price | $5.00 | $8.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $6.25 | ★ $21.71 |
| AVG Volume (30 Days) | ★ 2.1M | 919.5K |
| Earning Date | 02-04-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | ★ $525,092,000.00 | $84,388,000.00 |
| Revenue This Year | $13.99 | $333.25 |
| Revenue Next Year | $11.83 | $43.70 |
| P/E Ratio | ★ N/A | $16.67 |
| Revenue Growth | 6.82 | ★ 244.60 |
| 52 Week Low | $1.65 | $6.19 |
| 52 Week High | $8.28 | $13.16 |
Technical Indicators
Market Signals| Indicator | APPS | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 45.79 | 56.11 |
| Support Level | $5.00 | $8.59 |
| Resistance Level | $5.27 | $9.01 |
| Average True Range (ATR) | 0.26 | 0.33 |
| MACD | 0.02 | 0.12 |
| Stochastic Oscillator | 33.49 | 93.00 |
Price Performance
Historical ComparisonAbout APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.